Esther Larrea
8PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 28, 2026
Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by Leishmania major.Rima El-Dirany, Paolo Ginatta, Celia Fernández-Rubio
|Aug 28, 2025
The Role of BRCT Domain from LmjPES in Leishmania major Pathogenesis.Esther Larrea, José Peña-Guerrero, Celia Fernández-Rubio
|Nov 26, 2022
Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis.Rima El-Dirany, Celia Fernández-Rubio, José Peña-Guerrero
|Nov 11, 2022
The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells.Esther Larrea, Celia Fernández-Rubio, José Peña-Guerrero
|Nov 27, 2021
In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity.Miriam Algarabel, Celia Fernández-Rubio, Katerina Musilova
|Oct 29, 2020
LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome.Andrés Vacas, Celia Fernández-Rubio, Esther Larrea
Pageof 2
Frequent Collaborators
6 joint publications
Celia Fernández-Rubio
6 joint publications
Paul Nguewa
5 joint publications
José Peña-Guerrero
2 joint publications
Guillermo Martínez-de-Tejada
2 joint publications
Aroia Burguete-Mikeo
2 joint publications
Rima El-Dirany
2 joint publications
Elizabeth Guruceaga
2 joint publications
Andrés Vacas
1 joint publications
Puri Fortes
1 joint publications
Alba Calvo
